(Circulation. 2000;101:2682.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Predictors of Mortality and Mortality From Cardiac Causes in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial and Registry
From the University of Pittsburgh, Pittsburgh, Pa (M.M.B.); Duke University Medical Center, Durham, NC (R.H.J., R.M.C.); St Louis University Health Sciences Center, St Louis, Mo (R.G.B., B.R.C., M.J.K.); the Mayo Clinic, Rochester, Minn (T.A.O.); the National Heart, Lung, and Blood Institute, Bethesda, Md (D.F., G.S.); and the Cleveland Clinic, Cleveland, Ohio (E.H.B.).
Correspondence to Maria Mori Brooks, PhD, Epidemiology Data Center, University of Pittsburgh, 127 Parran Hall, Pittsburgh, PA 15261. E-mail brooks{at}edc.gsph.pitt.edu
Background—The impact of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG) on long-term mortality rates in the presence of various demographic, clinical, and angiographic factors is uncertain in the population of patients suitable for both procedures.
Methods and Results—In the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and registry, 3610 patients who were eligible to receive PTCA and CABG were revascularized between 1989 and 1992. Multivariate Cox models were used to identify factors associated with 5-year mortality and cardiac mortality, with particular attention to factors that interact with treatment. Diabetic patients receiving insulin had higher mortality and cardiac mortality rates with PTCA compared with CABG (relative risk [RR] 1.78 and 2.63, respectively, P<0.001), and patients with ST elevation had higher cardiac mortality rates with CABG than with PTCA (RR 4.08, P<0.001). Factors most strongly associated with high overall mortality rates were insulin-treated diabetes, congestive heart failure, kidney failure, and older age. Black race was also associated with higher mortality rates (RR 1.49, P=0.019).
Conclusions—A set of variables was identified that could be used to help select a revascularization procedure and to evaluate risk of long-term mortality in the population of patients considering revascularization.
Key Words: angioplasty • bypass • grafting • trials • mortality • diabetes mellitus
This article has been cited by other articles:
 |
|
 |
|
  D. M. Bravata, A. L. Gienger, K. M. McDonald, V. Sundaram, M. V. Perez, R. Varghese, J. R. Kapoor, R. Ardehali, D. K. Owens, and M. A. Hlatky Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med, November 20, 2007; 147(10): 703 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Bair, J. B. Muhlestein, H. T. May, K. G. Meredith, B. D. Horne, R. R. Pearson, Q. Li, K. R. Jensen, J. L. Anderson, and D. L. Lappe Surgical Revascularization Is Associated With Improved Long-Term Outcomes Compared With Percutaneous Stenting in Most Subgroups of Patients With Multivessel Coronary Artery Disease: Results From the Intermountain Heart Registry Circulation, September 11, 2007; 116(11_suppl): I-226 - I-231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kai, M. Hanyu, Y. Soga, T. Nomoto, J. Nakano, T. Matsuo, E. Umehara, M. Kawato, and H. Okabayashi Off-Pump Coronary Artery Bypass Grafting With Skeletonized Bilateral Internal Thoracic Arteries in Insulin-Dependent Diabetics Ann. Thorac. Surg., July 1, 2007; 84(1): 32 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Holmes Jr, L. J. Kim, M. M. Brooks, K. E. Kip, H. V. Schaff, K. M. Detre, R. L. Frye, and Bypass Angioplasty Revascularization Investigation The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 38 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. You, A. Ren, G. Yan, and J. Sun Activation of Sphingosine Kinase-1 Mediates Inhibition of Vascular Smooth Muscle Cell Apoptosis by Hyperglycemia Diabetes, May 1, 2007; 56(5): 1445 - 1453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Berry, J.-C. Tardif, and M. G. Bourassa Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization J. Am. Coll. Cardiol., February 13, 2007; 49(6): 643 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Rankin and F. E. Harrell Jr Measuring the therapeutic efficacy of coronary revascularization: Implications for future management J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 944 - 948. [Full Text] [PDF]
|
|
|
|
|
|
A. U. Momin, R. Deshpande, J. Potts, A. El-Gamel, M. T. Marrinan, J. Omigie, and J. B. Desai Incidence of Sternal Infection in Diabetic Patients Undergoing Bilateral Internal Thoracic Artery Grafting Ann. Thorac. Surg., November 1, 2005; 80(5): 1765 - 1772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zacharias, T. A. Schwann, C. J. Riordan, S. J. Durham, A. Shah, and R. H. Habib Operative and Late Coronary Artery Bypass Grafting Outcomes in Matched African-American Versus Caucasian Patients: Evidence of a Late Survival-Medicaid Association J. Am. Coll. Cardiol., October 18, 2005; 46(8): 1526 - 1535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Ramanathan, D. S. Weiman, J. Sacks, D. A. Morrison, S. Sedlis, G. Sethi, and W. G. Henderson Percutaneous Intervention Versus Coronary Bypass Surgery for Patients Older Than 70 Years of Age With High-Risk Unstable Angina Ann. Thorac. Surg., October 1, 2005; 80(4): 1340 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Flaherty, C. J. Davidson, J. R. Crouse III, S. A. Rubin, F. V. Mody, E. L. Hannan, G. Walford, and R. H. Jones Coronary-Artery Bypass Grafting versus Stent Implantation N. Engl. J. Med., August 18, 2005; 353(7): 735 - 737. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox) Chronic kidney disease as cause of cardiovascular morbidity and mortality Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dagogo-Jack Primary Prevention of Cardiovascular Disease in Pre-Diabetes: The glass is half full and half empty Diabetes Care, April 1, 2005; 28(4): 971 - 972. [Full Text] [PDF]
|
|
|
|
|
|
P. Calabro, I. Samudio, J. T. Willerson, and E. T.H. Yeh Resistin Promotes Smooth Muscle Cell Proliferation Through Activation of Extracellular Signal-Regulated Kinase 1/2 and Phosphatidylinositol 3-Kinase Pathways Circulation, November 23, 2004; 110(21): 3335 - 3340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. Smith IV, T. B. Ferguson Jr, T. Ryan, C. K. Landolfo, and E. D. Peterson Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement?: A decision analysis approach to the surgical dilemma J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1241 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Cutlip, A. G. Chhabra, D. S. Baim, M. S. Chauhan, S. Marulkar, J. Massaro, A. Bakhai, D. J. Cohen, R. E. Kuntz, and K. K.L. Ho Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials Circulation, September 7, 2004; 110(10): 1226 - 1230. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lichtenberg, U. Klima, H. Paeschke, M. Pichlmaier, S. Ringes-Lichtenberg, T. Walles, H. Goerler, and A. Haverich Impact of multivessel coronary artery disease on outcome after isolated minimally invasive bypass grafting of the left anterior descending artery Ann. Thorac. Surg., August 1, 2004; 78(2): 487 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lichtenberg, U. Klima, H. Paeschke, M. Pichlmaier, S. Ringes-Lichtenberg, T. Walles, H. Goerler, and A. Haverich Impact of diabetes on outcome following isolated minimally invasive bypass grafting of the left anterior descending artery Ann. Thorac. Surg., July 1, 2004; 78(1): 129 - 134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Athanasiou, M.-C. Crossman, G. Asimakopoulos, A. Cherian, A. Weerasinghe, B. Glenville, and R. Casula Should the internal thoracic artery be skeletonized? Ann. Thorac. Surg., June 1, 2004; 77(6): 2238 - 2246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pinkau, K. F. Hilgers, R. Veelken, and J. F. E. Mann How Does Minor Renal Dysfunction Influence Cardiovascular Risk and the Management of Cardiovascular Disease? J. Am. Soc. Nephrol., March 1, 2004; 15(3): 517 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Scott and K. C. Heslin Historical perspectives on the care of african americans with cardiovascular disease Ann. Thorac. Surg., October 1, 2003; 76(4): S1348 - 1355. [Full Text] [PDF]
|
|
|
|
|
|
C. R. Bridges Cardiac surgery in African Americans Ann. Thorac. Surg., October 1, 2003; 76(4): S1356 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Fox, V. Formanek, A. Friedrich, and S. K. Shernan Intraoperative Echocardiography Card. Surg. Adult, January 1, 2003; 2(2003): 283 - 314. [Full Text]
|
|
|
|
|
|
J. S. Rumsfeld, M. E. Plomondon, E. D. Peterson, M. G. Shlipak, C. Maynard, G. K. Grunwald, F. L. Grover, and A. L. W. Shroyer The impact of ethnicity on outcomes following coronary artery bypass graft surgery in the Veterans Health Administration J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1786 - 1793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Bittner, R. Hardison, S. F. Kelsey, B. H. Weiner, A. K. Jacobs, and G. Sopko Non-High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI) Circulation, November 12, 2002; 106(20): 2537 - 2542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Engoren, R. H. Habib, A. Zacharias, T. A. Schwann, C. J. Riordan, and S. J. Durham Effect of blood transfusion on long-term survival after cardiac operation Ann. Thorac. Surg., October 1, 2002; 74(4): 1180 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.A. Szczech, P.J. Best, E. Crowley, M.M. Brooks, P.B. Berger, V. Bittner, B.J. Gersh, R. Jones, R.M. Califf, H.H. Ting, et al. Outcomes of Patients With Chronic Renal Insufficiency in the Bypass Angioplasty Revascularization Investigation Circulation, May 14, 2002; 105(19): 2253 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Ferguson Jr, L. P. Coombs, and E. D. Peterson Internal thoracic artery grafting in the elderly patient undergoing coronary artery bypass grafting: Room for process improvement? J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 869 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Magee, T. M. Dewey, T. Acuff, J. R. Edgerton, J. F. Hebeler, S. L. Prince, and M. J. Mack Influence of diabetes on mortality and morbidity: off-pump coronary artery bypass grafting versus coronary artery bypass grafting with cardiopulmonary bypass Ann. Thorac. Surg., September 1, 2001; 72(3): 776 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Scott The challenges of health disparity and cardiovascular outcomes Ann. Thorac. Surg., February 1, 2001; 71(2): 405 - 406. [Full Text] [PDF]
|
|